November 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreJanuary 19, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreJanuary 15, 2026
Based on market forecasts, the dermatology sector will expand from USD 1.51 billion in 2025 to USD 2.95 billion by 2035, experiencing a CAGR of 6.94%. In 2024, Asia-Pacific led the global dermatology market, while North America is set for the fastest growth. Cosmetic dermatology dominated by product type, but surgical dermatology is expected to ris...
January 14, 2026
According to market projections, the global Parkinson’s disease diagnosis and treatment market, valued at USD 7.49 billion in 2025, is anticipated to reach USD 17.57 billion by 2035, growing at a CAGR of 8.9% over the next decade. In 2023, medications led the Parkinson’s disease market with a 40% share, while North America dominated at ...
January 14, 2026
Projections indicate that, the global anxiety disorders treatment market will increase from USD 12.33 billion in 2025 to USD 17.56 billion by 2035, experiencing a CAGR of 3.6% over the next 10 years. Anxiety disorder treatment helps manage excessive worry and fear through therapy, medication, or lifestyle changes. Common options include cognitive b...
January 14, 2026
Based on market forecasts, the chronic obstructive pulmonary disease sector will expand from USD 23.55 billion in 2025 to USD 36.29 billion by 2035, experiencing a CAGR of 4.42%. In 2023, North America led the COPD market, with chronic bronchitis and drug treatments taking the top spots. Hospitals and clinics were the key end users. Looking ahead, ...
January 14, 2026
Based on our forecasts, the behavioural mental health tools market was valued at USD 3.36 billion in 2025 and is expected to grow from USD 3.85 billion in 2026 to USD 13.28 billion by 2035, registering a CAGR of 14.74% during the forecast period....
January 13, 2026
Market insights predict the global rheumatoid arthritis drugs industry will increase from USD 19.55 billion in 2025 to USD 30.65 billion by 2035, achieving a CAGR of 4.6%. Rheumatoid arthritis (RA) drugs help reduce pain, swelling, and joint damage by controlling the immune system’s overactive response. Treatments include NSAIDs for pain, ste...
January 13, 2026
Projections indicate that, veterinary vaccines industry is projected to rise from USD 10.04 billion in 2025 to USD 18.11 billion by 2035, reflecting a CAGR of 6.07% over the next decade. The veterinary vaccines market is growing due to rising pet adoptions, increasing livestock production, and heightened awareness of animal disease prevention. No...
January 13, 2026
According to projections, the global topical drug delivery market, valued at USD 268.96 billion in 2025, is anticipated to reach USD 622.85 billion by 2035, growing at a CAGR of 8.76% over the next decade. A widespread increase in cases of diverse skin diseases is fueling enhanced adoption of topical treatments and overall global market expa...
January 13, 2026
According to our projections, the digital therapeutics for mental health market was valued at USD 3.74 billion in 2025 and is expected to reach USD 4.51 billion in 2026, expanding rapidly to approximately USD 24.42 billion by 2035, registering a strong CAGR of 20.64% from 2026 to 2035....
January 12, 2026
According to market projections, the huntington's disease treatment sector is expected to grow from USD 716.76 million in 2025 to USD 1519.02 million by 2035, reflecting a CAGR of 7.8%. Huntington's disease treatment focuses on managing symptoms, as there's no cure yet. Medications help control movement issues and mood changes, while therapy suppor...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com